Table 1

Patient diagnoses and bone marrow transplant details

Patient	Phenotype	Molecular diagnosis	Age at BMT	Type of BMT	Conditioning regimen	Admission length (days)	Time after last BMT (years)	Chimerism (T/B)
1	T⁻B⁺	cgc	68 days	Haplo TCD	Bu8;Cy200	226	11.5	D/mixed
2	T⁻B⁺NK⁺	Unknown	38 days	Haplo TCD	Bu8;Cy200	206	7.3	D/D
3	T⁻B⁺NK⁺	Unknown	35 days	Haplo TCD	Bu8;Cy200	210	6.7	D/R
4		T⁻B−NK⁺		Unknown		48 days	Pheno Whole	Nil	192
4		T⁻B−NK⁺		Unknown		2 years 5 months	Pheno Whole	Nil	16	3	D/mixed
5	T⁻B⁺NK⁺	Unknown	58 days	Haplo TCD	Bu8;Cy200;ATG6	171	4.8	D/mixed
6	T⁻B⁻NK⁻	ADA	93 days	URD TCD	Bu16;Cy200	230	4.3	D/mixed
7		T⁻B⁻NK⁻	Unknown		66 days	URD TCD	Bu8;Cy200	201
		Radiosensitive			302 days	URD TCD	Nil	214
		Radiosensitive			2.5 years	Haplo TCD	Bu16;Cy200;ATG6	157	1.5	D/Unknown
8	T⁻B⁺NK⁺	Unknown	45 days	Haplo TCD	Bu8;Cy200	172	3.2	D/R
9		T⁻B⁻NK⁺		RAG2		41 days	Haplo TCD	Bu8;Cy200	144
						1 year 5 months	Haplo TCD	Nil	1
						2 years 1 month	Haplo TCD	Bu16;Cy200	64	0.5	D/Unknown
10	T⁻B⁻NK⁻	ADA	39 days	Sib Whole	Nil	58	2.3	D/mixed
11	T⁻B⁻NK⁻	ADA	33 days	Sib Whole	Nil	83	2	D/mixed
12	T⁻B⁻NK⁺	Unknown	7 days	Sib Cord Blood	Nil	56	1.6	D/mixed
13	T⁻B⁺	cgc	45 days	Haplo TCD	Bu8;Cy200	168	1.3	D/R

cgc, Common interleukin gamma chain deficiency; ADA, adenosine deaminase deficiency; RAG2, recombination activation gene 2 deficiency; Haplo, haplo-identical; TCD, T cell depleted; Pheno, phenotypic; URD, unrelated donor; Sib, sibling; Bu, busulfan; Cy, cyclophosphamide; ATG, anti-thymocyte globulin; BMT, bone marrow transplant; T/B, T lymphocytes/B lymphocytes; D, donor; R, recipient.